About Us

Advanced Genetic Systems, Inc. (AGS) is a drug discovery company dedicated to pioneering novel classes of antiviral therapeutics.

At AGS we have focused our drug discovery efforts on an under-explored target, the Ribonucleoprotein (RNP) complex. RNPs are composed of interactions between structural RNA and proteins. Targeting RNPs is challenging due to the multiple roles, dynamic conformations, and chemical instability of these complexes. To address these challenges, we have developed two key tools. First, we have built a robust cell-based screening platform dedicated to targeting this class of interaction. Second, we have developed novel chemical strategies including the assembly and screening of custom libraries tailored to the chemistry of RNPs.